NEWS

CHEMI-PHARM IS ONE OF THE NOMINEES IN “INNOVATOR OF THE YEAR 2021”

Read more

SARS-COV-2 ANTIBODIES IN BIOBLOCK NASAL SPRAY PROVEN TO SUPPRESS DELTA VARIANT

Read more

A NEW BATCH OF BIOBLOCK NASAL SPRAY ARRIVED IN PHARMACIES

Read more

CLINICAL TRIALS OF BIOBLOCK NASAL SPRAY WITH CORONAVIRUS ANTIBODIES ARE BEGINNING

Read more

AS CHEMI-PHARM AND INNOPOLIS INSENERID OÜ ENTERED INTO AN AGREEMENT FOR THE DESIGN OF A PHARMACEUTICAL FACTORY

Read more

TECHNOLOGY FOR THE MANUFACTURE OF SARS-COV-2 BIOBLOCK NASAL AND THROAT SPRAY BASED ON ANTIBODIES AGAINST SARS-COV-2 CORONA VIRUS WAS DEVELOPED AND PATENTED IN COOPERATION BETWEEN COMPANIES AND UNIVERSITIES

Read more

“IMPROVING THE PRODUCTION OF DISINFECTANTS THROUGH FULL AUTOMATION”

Read more

WITH THE HELP OF THE ESTONIAN-NORWEGIAN COOPERATION PROJECT GREEN ICT, CHEMI-PHARM’S PRODUCTION PROCESS WILL BE MORE EFFICIENT AND THERE WILL BE A REMARKABLE INCREASE OF UNITS PRODUCED WITHIN THE SAME WORKING HOURS

Read more

INTRODUCING: CHEMI-PHARM

Read more
12